Biomerica (BMRA) Accumulated Expenses (2011 - 2026)

Biomerica has disclosed Accumulated Expenses across 16 years of filings, most recently posting $608000.0 for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $608000.0, down 0.65% year-over-year; the trailing twelve-month figure through Feb 2026 was $608000.0 (down 0.65% YoY), and the FY2025 annual result was $655000.0, up 13.32% from the prior year.
• Accumulated Expenses came in at $608000.0 for Q1 2026 at Biomerica, up from $545000.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $702000.0 in Q1 2024 to a low of $236000.0 in Q2 2022.
• The 5-year median for Accumulated Expenses is $601000.0 (2024), against an average of $588286.4.
• Across the five-year window, Accumulated Expenses jumped 132.2% in 2023 and fell 12.82% in 2025, its largest moves.
• Biomerica's Accumulated Expenses stood at $697179.0 in 2022, then retreated by 4.19% to $668000.0 in 2023, then declined by 10.03% to $601000.0 in 2024, then declined by 9.32% to $545000.0 in 2025, then advanced by 11.56% to $608000.0 in 2026.
• The last three Accumulated Expenses figures came in at $608000.0 (Q1 2026), $545000.0 (Q4 2025), and $591000.0 (Q3 2025), per Business Quant data.